What is NU100 used for?

NU100 is indicated for Relapsing forms of multiple sclerosis.

NU100 is developed by Nuron Biotech Inc..

What are the side effects of NU100?

Common side effects include Headache, Nausea, Diarrhea.

Last reviewed 2026-04-23 · How we verify

NU100

Nuron Biotech Inc. · Phase 3 active Biologic

NU100 is a small molecule that targets the S1P1 receptor.

NU100 is a small molecule that targets the S1P1 receptor. Used for Relapsing forms of multiple sclerosis.

At a glance

Generic name	NU100
Sponsor	Nuron Biotech Inc.
Drug class	S1P1 receptor modulator
Target	S1P1
Modality	Biologic
Therapeutic area	Multiple Sclerosis
Phase	Phase 3

Mechanism of action

NU100 works by selectively modulating the sphingosine-1-phosphate 1 (S1P1) receptor, which plays a key role in the regulation of lymphocyte trafficking and immune responses.

Approved indications

Relapsing forms of multiple sclerosis

Common side effects

Headache
Nausea
Diarrhea

Key clinical trials

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NU100 CI brief — competitive landscape report
NU100 updates RSS · CI watch RSS
Nuron Biotech Inc. portfolio CI